Back
Kymera Therapeutics, Inc. Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
72
KYMR
Kymera Therapeutics, Inc.
Last Price:
$66.69
Seasonality Move:
7.7%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Kymera Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.47 | Buy |
| 20-day SMA: | 64.83 | Buy |
| 50-day SMA: | 61.21 | Buy |
| 200-day SMA: | 43.96 | Buy |
| 8-day EMA: | 66.09 | Buy |
| 20-day EMA: | 64.75 | Buy |
| 50-day EMA: | 60.61 | Buy |
| 200-day EMA: | 48.97 | Buy |
Kymera Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 60.29 | Buy |
| Chaikin Money Flow: | 254539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.36 - 66.56) | Buy |
| Bollinger Bands (100): | (43.77 - 61.91) | Buy |
Kymera Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics, Inc. Stock
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 66.62 while KYMR 8-day simple moving average is 66.47, which is a Buy signal.
-
The stock price of KYMR is 66.62 while Kymera Therapeutics, Inc. 20-day SMA is 64.83, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day simple moving average is 61.21 while KYMR share price is 66.62, making it a Buy technically.
-
KYMR stock price is 66.62 and Kymera Therapeutics, Inc. 200-day simple moving average is 43.96, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
72
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy or a Sell?
-
Kymera Therapeutics, Inc. stock is rated a BuyThe current Kymera Therapeutics, Inc. [KYMR] share price is $66.62. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics, Inc. Stock Info
Market Cap:
4.8B
Price in USD:
66.62
Share Volume:
392.7K
Kymera Therapeutics, Inc. 52-Week Range
52-Week High:
68.80
52-Week Low:
19.45
Buy
72
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Kymera Therapeutics, Inc. Share Price Forecast
-
What is the Kymera Therapeutics, Inc. stock price today?The Kymera Therapeutics, Inc. stock price is 66.62 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics, Inc. is not overvalued.
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 66.62 while KYMR 8-day exponential moving average is 66.09, which is a Buy signal.
-
The stock price of KYMR is 66.62 while Kymera Therapeutics, Inc. 20-day EMA is 64.75, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day exponential moving average is 60.61 while KYMR share price is 66.62, making it a Buy technically.
-
KYMR stock price is 66.62 and Kymera Therapeutics, Inc. 200-day simple moving average is 48.97, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics, Inc.
Is Kymera Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Kymera Therapeutics, Inc.
Should I short Kymera Therapeutics, Inc. stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 1.78, suggesting Kymera Therapeutics, Inc. is a Buy
-
Kymera Therapeutics, Inc. Relative Strength Index (RSI) is 60.29, which suggest Kymera Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics, Inc. is (61.36 - 66.56), which suggest Kymera Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics, Inc. is (43.77 - 61.91), which suggest Kymera Therapeutics, Inc. is a Buy
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.